ACCORD HEALTHCARE

CARMUSTINE

Manufacturer:

ACCORD HEALTHCARE

Carmustine HCPCS:

J9052

HCPCS Code Descriptor:

Injection, carmustine (accord), not therapeutically equivalent to j9050, 100 mg

Category:

J Code

Carmustine NDCs:

16729-0548-63, 16729-0545-63

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Carmustine:

CARMUSTINE is a Oncology drug manufactured by ACCORD HEALTHCARE and administered via the Intravenous route of administration. The J Code: J9052 is aligned to the drug CARMUSTINE.

Carmustine is a type of chemotherapy drug given to patients with a variety of cancers, such as brain tumors, Hodgkin's disease, multiple myeloma, and non-Hodgkin's lymphoma. Carmustine is a type of drug known as alkylating agent. It works by interfering with the DNA in cancer cells. This prevents the cells from dividing, thus stopping the cancer from growing and spreading.

ACCESS PRICING AND MORE BY REGISTERING

J9052 Added Date:

January 1, 2024

J9052 Effective Date:

January 1, 2024

J9052 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Carmustine billing and coding information.
Our team did not identify a source for Carmustine patient assistance information. Please reach out to our team if you feel that this is a mistake.
CARMUSTINE prescribing information can be found at the link below:
Information regarding CARMUSTINE’s side effects can be found at MedlinePlus